Search by Drug Name or NDC

    NDC 24338-0008-90 Adthyza Thyroid 57; 13.5 ug/1; ug/1 Details

    Adthyza Thyroid 57; 13.5 ug/1; ug/1

    Adthyza Thyroid is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Azurity Pharmaceuticals, Inc.. The primary component is LEVOTHYROXINE; LIOTHYRONINE.

    Product Information

    NDC 24338-0008
    Product ID 24338-008_4456cfa6-da14-45fb-8794-899fcea1c43f
    Associated GPIs
    GCN Sequence Number 065424
    GCN Sequence Number Description thyroid,pork TABLET 90 MG ORAL
    HIC3 P3A
    HIC3 Description THYROID HORMONES
    GCN 27385
    HICL Sequence Number 002846
    HICL Sequence Number Description THYROID,PORK
    Brand/Generic Generic
    Proprietary Name Adthyza Thyroid
    Proprietary Name Suffix n/a
    Non-Proprietary Name Levothyroxine and Liothyronine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 57; 13.5
    Active Ingredient Units ug/1; ug/1
    Substance Name LEVOTHYROXINE; LIOTHYRONINE
    Labeler Name Azurity Pharmaceuticals, Inc.
    Pharmaceutical Class Thyroxine [CS], Triiodothyronine [CS], l-Thyroxine [EPC], l-Triiodothyronine [EPC]
    DEA Schedule n/a
    Marketing Category UNAPPROVED DRUG OTHER
    Application Number n/a
    Listing Certified Through 2024-12-31

    Package

    NDC 24338-0008-90 (24338000890)

    NDC Package Code 24338-008-90
    Billing NDC 24338000890
    Package 90 TABLET in 1 BOTTLE (24338-008-90)
    Marketing Start Date 2023-12-18
    NDC Exclude Flag N
    Pricing Information N/A